Global Thermal Ablation Devices Market Size By Type (Interstitial Probes, Grounded Probes), By Application (Hospitals, Ambulatory Surgical Centers (ASCs)), By Region, And Segment Forecasts, 2023 to 20...

The Global Thermal Ablation Devices Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 6.8 billion by 2031, growing at a CAGR of 10.2% during the forecast period from 2023 to 2031. The market is experiencing robust growth driven by the increasing prevalence of cancer, rising demand for minimally invasive procedures, and advancements in thermal ablation technologies. Thermal ablation devices, including microwave, radiofrequency, and laser systems, are being increasingly used to treat tumors in the liver, lungs, kidneys, and bones, offering patients faster recovery and fewer complications compared to conventional surgical procedures.

Drivers

Rising Cancer Incidence

The increasing global cancer burden is one of the primary drivers of the thermal ablation devices market. As cancer rates rise, particularly liver, kidney, and lung cancers, thermal ablation is becoming a vital option for localized tumor treatment.

Minimally Invasive Procedures

Thermal ablation technologies offer a non-surgical alternative with shorter hospital stays, reduced pain, and lower healthcare costs, which are attracting both patients and healthcare providers.

Technological Advancements

Continuous innovations in thermal ablation devices, such as real-time imaging, advanced probes, and AI-guided systems, are enhancing treatment precision and expanding the clinical applicability of these devices.

Restraints

High Equipment Costs

The significant capital investment required for thermal ablation systems and accessories can deter adoption, especially in low-resource settings or smaller healthcare facilities.

Limited Skilled Professionals

The successful use of thermal ablation depends on highly skilled interventional radiologists or oncologists. A shortage of trained professionals can limit the adoption rate in some regions.

Opportunities

Emerging Markets

Rapid healthcare infrastructure development in countries such as India, China, and Brazil presents lucrative opportunities for market players, particularly as awareness about minimally invasive cancer treatments increases.

Expansion into Non-Oncology Applications

Beyond oncology, thermal ablation is gaining traction in treating benign conditions such as varicose veins and cardiac arrhythmias, offering new revenue streams for device manufacturers.

Market by System Type Insights

The Radiofrequency Ablation (RFA) segment dominated the market in 2023, accounting for the largest share due to its widespread clinical acceptance and established efficacy in treating hepatic and renal tumors. However, Microwave Ablation (MWA) is expected to register the highest growth rate through 2031 owing to its superior heating capacity, faster procedure times, and effectiveness in larger tumor volumes.

Market by End-use Insights

In 2023, Hospitals represented the largest end-use segment, supported by the availability of advanced infrastructure and skilled personnel. Ambulatory Surgical Centers (ASCs) are projected to witness significant growth due to increasing preference for outpatient procedures that reduce treatment costs and recovery time.

Market by Regional Insights

North America led the global thermal ablation devices market in 2023, driven by advanced healthcare systems, high cancer incidence rates, and favorable reimbursement policies. Meanwhile, Asia-Pacific is expected to experience the fastest growth during the forecast period due to growing healthcare investments, rising patient awareness, and increasing adoption of technologically advanced treatments.

Competitive Scenario

Key players in the global thermal ablation devices market include:

Medtronic plc

Boston Scientific Corporation

AngioDynamics, Inc.

Johnson & Johnson (Ethicon, Inc.)

Olympus Corporation

Stryker Corporation

EDAP TMS

Integra LifeSciences Corporation

Smith & Nephew plc

BTG International Ltd.

These companies are focusing on product innovation, geographic expansion, and strategic collaborations. For example:

In 2023, Medtronic launched an advanced microwave ablation system with integrated imaging guidance to enhance tumor targeting.

Boston Scientific expanded its oncology product line in 2024 by acquiring a leading startup specializing in AI-powered ablation planning tools.

Scope of Work – Global Thermal Ablation Devices Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 6.8 billion

CAGR (2023–2031) 10.2%

Market Segments By System Type (RFA, MWA, Cryoablation, Others); By End-Use (Hospitals, ASCs, Clinics)

Growth Drivers Rising cancer incidence, demand for minimally invasive procedures, technological advancements

Opportunities Emerging markets, non-oncology applications

Key Market Developments

2023: Medtronic launched the AccuAblate™ system, integrating real-time thermometry and AI-gu